UAE Women's Health Market Size & Outlook, 2025-2030

The women's health market in the UAE is expected to reach a projected revenue of US$ 256.3 million by 2030. A compound annual growth rate of 5% is expected of the UAE women's health market from 2025 to 2030.
Revenue, 2024 (US$M)
$185.7
Forecast, 2030 (US$M)
$256.3
CAGR, 2025 - 2030
5%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE women's health market, 2018-2030 (US$M)

UAE women's health market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE women's health market highlights

  • The UAE women's health market generated a revenue of USD 185.7 million in 2024 and is expected to reach USD 256.3 million by 2030.
  • The UAE market is expected to grow at a CAGR of 5% from 2025 to 2030.
  • In terms of segment, contraceptives was the largest revenue generating application in 2024.
  • Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.


Women's health market data book summary

Market revenue in 2024USD 185.7 million
Market revenue in 2030USD 256.3 million
Growth rate5% (CAGR from 2025 to 2030)
Largest segmentContraceptives
Fastest growing segmentEndometriosis & Uterine Fibroids
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPostmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Hormonal Infertility, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)
Key market players worldwideAbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring


Other key industry trends

  • In terms of revenue, UAE accounted for 0.4% of the global women's health market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia women's health market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 330.8 million by 2030.

Contraceptives was the largest segment with a revenue share of 38.66% in 2024. Horizon Databook has segmented the UAE women's health market based on postmenopausal osteoporosis, endometriosis & uterine fibroids, hormonal infertility, contraceptives, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.


Increasing health concerns about lifestyle disorders, rising awareness about women's health, and growing prevalence of target diseases are some of the key factors driving the market in the country. According to International Osteoporosis Foundation, the estimated prevalence of osteoporosis hip fractures is 2.25 cases per 1,000 population annually in Abu Dhabi.

The UAE pharmaceuticals market is witnessing rapid growth. Although the UAE currently imports the majority of its pharmaceuticals, the scenario is expected to change, as some international pharmaceutical giants have partnered with UAE companies to manufacture products in the country.

Furthermore, the growing pharmaceutical sector in the UAE is another factor fueling the market growth. For instance, in February 2020, Neopharma and GSK plc launched the first locally produced batch of medicines. The main objective of this partnership is to generate manufacturing opportunities in the UAE.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Companies

Name Profile # Employees HQ Website
Apothecus View profile 11-50 Hicksville, New York, United States, North America https://apothecus.com
Blairex Laboratories View profile 101-250 Columbus, Indiana, United States, North America http://www.blairex.com
Agile Therapeutics Inc View profile 19 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 https://www.agiletherapeutics.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

UAE Application - Women's Health Market size, 2024 - 2030 (US$M)

UAE Women's Health Market Outlook Share, 2024 & 2030 (US$M)

UAE Application - Women's Health Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online